CAS 1402727-29-0

PE859

CAS: 1402727-29-0

PE859

Formel: C₂₈H₂₄N₄O₂

Reinheit: ≥98%

Molekulargewicht: 448.52

Ref: 54-BUP09397

PE859

CAS: 1402727-29-0

Formel: C₂₈H₂₄N₄O₂

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 448.5158

Ref: IN-DA01EOOF

6-((E)-2-(3-((E)-2-Methoxy-4-(Pyridin-2-Ylmethoxy)Styryl)-1H-Pyrazol-5-Yl)Vinyl)-1H-Indole

CAS: 1402727-29-0

6-((E)-2-(3-((E)-2-Methoxy-4-(Pyridin-2-Ylmethoxy)Styryl)-1H-Pyrazol-5-Yl)Vinyl)-1H-Indole

Formel: C₂₈H₂₄N₄O₂

Reinheit: 99%

Molekulargewicht: 448.52

Ref: 54-OR1024174

PE859

CAS: 1402727-29-0

PE859 is a potent inhibitor of both tau and Aβ aggregation.

Formel: C₂₈H₂₄N₄O₂

Reinheit: 98.8% - 99.09%

Farbe und Form: Solid

Molekulargewicht: 448.52

Ref: TM-T4077

PE859

CAS: 1402727-29-0

PE859 is a small molecule that inhibits the activity of the enzyme beta-site amyloid precursor protein cleaving enzyme 1 (BACE1). It has been shown to reduce plaque formation and ameliorate symptoms in an Alzheimer's disease mouse model. PE859 also has antiviral properties, which have been demonstrated using a cell culture system and microscopy studies. The mechanism of action for its antiviral properties is not known, but may be related to its ability to inhibit BACE1 activity.

Formel: C₂₈H₂₄N₄O₂

Reinheit: Min. 95%

Molekulargewicht: 448.52 g/mol

Ref: 3D-CGC72729